Dissolution with immediate closure of the liquidation
Dissolved and wound up in a single deed · Books and records kept in Ghent (5 years) · Name after signing inVisible after signing in (director) and Name hiddenVisible after signing in (director) resign · General meeting of 26-10-2026 · Gazette deed
Listed in the Peppol Directory
2 directors resigning, 2 reappointmentsHidden nameVisible after signing in (director) and Name after signing inVisible after signing in (director) resign · Name hiddenVisible after signing in (director) and Hidden nameVisible after signing in (director) reappointed · Gazette deed
Capital decrease of €405,000 to €20,000
The capital fell from €425,000 to €20,000 · General meeting of 18-12-2017 · Gazette deed
“Het verschaffen van advies aan en vergemakkelijken van transacties tussen biofarmaceutische bedrijven voor het…” (deed in Dutch)From the articles, 4 activitiesNo NACE code in the KBO
Dissolved and wound up in a single deed on 30-10-2026. The last annual accounts are for financial year 2025. The company was dissolved and wound up in a single deed. The books and records are kept for 5 years in Ghent.
The company number of PHARMABRIDGE is 0865.863.867. The VAT number is the same number with BE in front: BE 0865.863.867.
What is the legal form of PHARMABRIDGE?
PHARMABRIDGE is a private limited company (BV).
Is PHARMABRIDGE still active?
No. Dissolved and wound up in a single deed on 30-10-2026. The company has been out of the KBO register since 29-10-2026.Company details
What is the turnover of PHARMABRIDGE?
The turnover in financial year 2025 is about €110,000. This figure is estimated from the gross margin of €15,141 and 7,100 comparable companies of the same size. It probably lies between €51,000 and €270,000. It is a rough estimate.Financials
Is PHARMABRIDGE profitable?
In financial year 2025, PHARMABRIDGE made a loss of €7,579.
Where can I find the annual accounts of PHARMABRIDGE?
PHARMABRIDGE filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.